Abstract
IntroductionRubella cases are often under-reported, especially in many developing countries, owing to inadequate attention and weak funding of elimination strategies, despite being an epidemic-prone disease. Based on available data, this paper, therefore, seeks to bring the attention of public health practitioners, researchers and policy makers to threats of rubella in our environment, and also recommend measures to mitigate the threats.MethodsThe authors conducted a retrospective cross-sectional study in which the laboratory results of febrile-rash-illness cases in Kebbi State, Northwest Nigeria, from January 1, 2014 to December 31, 2015 were analysed, using descriptive statistics and chi-square test. We obtained the data set through the routine Integrated Disease Surveillance System and Response being conducted in Nigeria.ResultsA total of 413 febrile-rash-illness cases were reported and investigated in Kebbi State from 2014 to 2015, 5 (3.5%) tested positive for rubella IgM in 2014 while 7(2.6%) tested positive in 2015. There was no statistically significant difference in the incidence of rubella between 2014 and 2015 (p> 0.05). Rubella infection was mainly found in children less than 5 years of age with peak incidence period during the hot season (between February and April). There was no significant sex bias in this study. However, our practice experiences in this environment suggest a systematic under-reporting and under-diagnosis of febrile- rash-illnesses.ConclusionThere was no statistically significant difference in the incidence of rubella in children in our setting for the 2-years studied. However, there is a potential for increase in the transmission of the disease due to non-availability of routine childhood vaccination against rubella and the systematic under-reporting of suspected cases and weak laboratory support. In order to better appreciate the burden of rubella infection, there may be a need to undertake a prevalence survey, and simultaneously, strengthening case-based surveillance in Northwestern Nigeria. Further, WHO should support national government in accelerating the introduction of rubella-containing vaccine to stem the potential spread of this infectious disease.
Highlights
Rubella cases are often under-reported, especially in many developing countries, owing to inadequate attention and weak funding of elimination strategies, despite being an epidemic-prone disease
The results showed that more rubella infections were reported among under-5 years children (58.3%), followed by children in the age group 5-9 years (41.7%) while none was reported among ≥10years
This study explores the occurrence of rubella in a northwestern state of Nigeria with the aim of understanding the epidemiology of rubella in this environment and to add to the clamor for the introduction of rubella-containing vaccines (RCVs) into routine immunization schedule as well as strengthening of surveillance for febrile-rash illnesses in Nigeria
Summary
Rubella cases are often under-reported, especially in many developing countries, owing to inadequate attention and weak funding of elimination strategies, despite being an epidemic-prone disease. Conclusion: There was no statistically significant difference in the incidence of rubella in children in our setting for the 2-years studied. The study revealed that the majority (95%) of rubella cases reported had occurred in children up to 14 years of age while 6-16% of women of child-bearing age (15 to 49 years) in the region are susceptible to rubella. Prior to the introduction of rubella vaccine, the incidence of CRS varied from 0.1-0.2/1000 live births during endemic periods, and 0.8-4/1000 live births during rubella epidemics [8,9] These are essentially studies done in developed countries but little data are available in this part of the world-developing countries. There had been reduced incidences of CRS in regions that had attained increased coverage with rubella vaccine during 1996-2008 [8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.